Influence of Underlying Disease on Busulfan Disposition in Pediatric Bone Marrow Transplant Recipients: A Nonparametric Population Pharmacokinetic Study-Reference-Cited by-同舟云学术

Influence of Underlying Disease on Busulfan Disposition in Pediatric Bone Marrow Transplant Recipients: A Nonparametric Population Pharmacokinetic Study

Published:2007-04 Issue:2 Volume:29 Page:177-184
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Bertholle-Bonnet V,Bleyzac N,Galambrun C,Mialou V,Bertrand Y,Souillet G,Aulagner G

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference26 articles.

1. Association of busulfan area under the curve with veno-occlusive disease following BMT.;Dix;Bone Marrow Transplant,1996

2. Aspect concerning busulfan pharmacokinetics and bioavailability.;Hassan;Leuk Lymphoma,1996

3. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patient undergoing bone marrow transplantation.;Grochow;Cancer Chemother Pharmacol,1989

4. An improved limited sampling method for individualized busulfan dosing in bone marrow transplantation in children.;Chattergoon;Bone Marrow Transplant,1997

5. Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation.;Slattery;Ther Drug Monit,1998

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience;Pharmaceutics;2023-12-20

2. Busulfan Interlaboratory Proficiency Testing Program Revealed Worldwide Errors in Drug Quantitation and Dose Recommendations;Therapeutic Drug Monitoring;2023-05-12

3. Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions;Expert Opinion on Drug Metabolism & Toxicology;2023-02-01

4. Busulfan dose Recommendation in Inherited Metabolic Disorders: Population Pharmacokinetic Analysis;Transplantation and Cellular Therapy;2022-02

5. Gallic acid ameliorates busulfan-induced testicular toxicity and damage in mature rats;Drug and Chemical Toxicology;2021-03-18